Group: FDA wants but isn't requiring INDs for C. diff transplants

07/15/2013 | BeckersASC.com

While the FDA has said it will not require an investigational new drug applications for fecal microbiota transplants, the agency still is encouraging doctors to forward an application before beginning the procedure, according to the American Gastroenterological Association.

View Full Article in:

BeckersASC.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC